This site is intended for healthcare professionals
Micrograph of bone marrow rendered in pinks and purples

Find disease awareness content and relevant supporting materials

    Learning Zone CME Events News Trials Guidelines Journals
    Filter results
    Sort by:
    Relevance
    to
    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    05/06/15

    FDA approves Radiesse dermal filler for hand augmentation-Merz North America

    Merz North America has announced that Radiesse has received FDA approval for hand augmentation to correct volume loss in the...

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    20/12/15

    FDA approves Fenix Continence Restoration System to treat faecal incontinence- Torax Medical

    The FDA has approved the Fenix Continence Restoration System from Torax Medical to treat faecal incontinence in patients who are...

    Guidelines
    Guideline
    01/04/25

    Alpha-1-antitrypsin deficiency targeted testing and augmentation therapy: A Canadian Thoracic Society meta-analysis and clinical practice guideline

    The Canadian Thoracic Society's guidelines on alpha-1 antitrypsin deficiency (AATD) focus on targeted testing and augmentation therapy. They emphasize early diagnosis using genetic testing and recommend augmentation therapy for severe cases.

    • Source: Canadian Thoracic Society
    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    06/10/13

    Tecfidera (Biogen) effective in MS over the longterm

    Data presented by Biogen IDEC show that Tecfidera (dimethyl fumarate) continues to offer consistent and strong efficacy combined with a...

    Journals
    Journal
    01/06/20

    Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment-resistant major depressive disorder

    Aim: A substantial proportion of major depressive disorder patients are treatment‐resistant to antidepressant therapy, who require augmentation drugs, or other treatments including electroconvulsive therapy or transcranial magnetic stimulation.

    • Source: Neuropsychopharmacology Reports
    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    23/02/13

    New data shows benefits of Linx Reflux System (Torax Medical Inc) for patients with GERD

    A new study provides evidence of safety and effectiveness for the Linx Reflux Management System, from Torax Medical Inc, for...

    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    22/08/24

    Abbott advances heart failure management with aspirin free regimen for patients receiving the HeartMate 3 heart pump.

    Abbott announced that the FDA has approved a change to its label that will help patients who receive a HeartMate 3 left ventricular assist device (LVAD, or heart pump) experience superior clinical outcomes by eliminating aspirin as part of routine patient management

    Journals
    Journal
    01/09/22

    Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II

    Objectives: To assess the efficacy and safety of ofatumumab versus teriflunomide in recently diagnosed, treatment-naive (RDTN) participants from ASCLEPIOS.

    • Source: Multiple Sclerosis Journal
    Journals
    Journal
    31/12/18

    Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis

    Aims: We conducted a systematic review and meta-analysis to search and quantify the evidence of psychological and pharmacological augmentation interventions for TRD.

    • Source: The British Journal of Psychiatry
    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    04/07/15

    FDA approves Restylane Lyft for cheek augmentation- Galderma

    Galderma announced that it has received FDA approval to market Restylane Lyft for cheek augmentation and the correction of age-related...

    See more